83 related articles for article (PubMed ID: 27919957)
1. Simultaneous Administration of Statins and Pioglitazone Limits Tumor Growth in a Rat Model of Malignant Glioma.
Tapia-Pérez JH; Preininger R; Kirches E; Reinhold A; Butzmann J; Prilloff S; Mawrin C; Schneider T
Anticancer Res; 2016 Dec; 36(12):6357-6365. PubMed ID: 27919957
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
Papi A; Tatenhorst L; Terwel D; Hermes M; Kummer MP; Orlandi M; Heneka MT
J Neurochem; 2009 Jun; 109(6):1779-90. PubMed ID: 19457135
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts.
Spagnolo A; Glick RP; Lin H; Cohen EP; Feinstein DL; Lichtor T
J Neurosurg; 2007 Feb; 106(2):299-305. PubMed ID: 17410715
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells.
Tapia-Pérez JH; Kirches E; Mawrin C; Firsching R; Schneider T
Cancer Chemother Pharmacol; 2011 May; 67(5):1193-201. PubMed ID: 21120479
[TBL] [Abstract][Full Text] [Related]
6. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.
Kinouchi T; Kitazato KT; Shimada K; Yagi K; Tada Y; Matsushita N; Sumiyoshi M; Satomi J; Kageji T; Nagahiro S
Stroke; 2012 Feb; 43(2):478-83. PubMed ID: 22076002
[TBL] [Abstract][Full Text] [Related]
7. A model for evaluating therapeutic response of combined cancer treatment modalities: applied to treatment of subcutaneously implanted brain tumors (N32 and N29) in Fischer rats with pulsed electric fields (PEF) and 60Co-gamma radiation (RT).
Persson BR; Bauréus Koch C; Grafstrom G; Engstrom PE; Salford LG
Technol Cancer Res Treat; 2003 Oct; 2(5):459-70. PubMed ID: 14529312
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
9. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin reduces functional deficits caused by photodynamic therapy in rats.
Zheng X; Chopp M; Lu Y; Jiang J; Zhao D; Ding C; Yang H; Zhang L; Jiang F
Int J Oncol; 2011 Nov; 39(5):1133-41. PubMed ID: 21850369
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of statins and thiazolidinediones on meningioma cells.
Gehring S; Tapia-Pérez JH; Kirches E; Firsching R; Keilhoff G; Schneider T; Mawrin C
J Neurooncol; 2011 May; 102(3):383-93. PubMed ID: 20803306
[TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2.
Tzeng JJ; Barth RF; Clendenon NR; Gordon WA
Cancer Res; 1990 Jul; 50(14):4338-43. PubMed ID: 2364388
[TBL] [Abstract][Full Text] [Related]
13. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone improves insulin sensitivity and reduces weight loss in Walker-256 tumor-bearing rats.
de Fatima Silva F; Ortiz-Silva M; de Souza Galia WB; Cassolla P; Graciano MF; Zaia CT; Zaia D; Carpinelli ÂR; da Silva FG; de Souza HM
Life Sci; 2017 Feb; 171():68-74. PubMed ID: 28034669
[TBL] [Abstract][Full Text] [Related]
15. The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.
Grommes C; Karlo JC; Caprariello A; Blankenship D; Dechant A; Landreth GE
Cancer Chemother Pharmacol; 2013 Apr; 71(4):929-36. PubMed ID: 23358645
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice.
Russo E; Donato di Paola E; Gareri P; Siniscalchi A; Labate A; Gallelli L; Citraro R; De Sarro G
Pharmacol Res; 2013 Apr; 70(1):1-12. PubMed ID: 23253428
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a human glioblastoma stemlike brainstem rodent tumor model.
Siu IM; Tyler BM; Chen JX; Eberhart CG; Thomale UW; Olivi A; Jallo GI; Riggins GJ; Gallia GL
J Neurosurg Pediatr; 2010 Jul; 6(1):92-7. PubMed ID: 20593994
[TBL] [Abstract][Full Text] [Related]
18. Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis.
Suke SG; Negi H; Mediratta PK; Banerjee BD; Sharma KK
Eur J Pharmacol; 2013 Oct; 718(1-3):57-62. PubMed ID: 24075936
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole.
Khalid MH; Tokunaga Y; Caputy AJ; Walters E
J Neurosurg; 2005 Jul; 103(1):79-86. PubMed ID: 16121977
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M
Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
